Chemical Structure : MLKL inhibitor P28
货号: PC-21159Not For Human Use, Lab Use Only.
MLKL inhibitor P28 is a potent inhibitor of necroptosis via MLKL inhibition (EC50=10.3 uM), blocks oligomerization and translocation of MLKL.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MLKL inhibitor P28 is a potent inhibitor of necroptosis via MLKL inhibition (EC50=10.3 uM), blocks oligomerization and translocation of MLKL.
MLKL inhibitor P28 is more potent than Necrosulfonamide (NSA, Cat#PC-42202) in preventing cell death after exposure to necroptotic stimuli at a concentration of 0.1 μM.
MLKL inhibitor P28 (3 uM) inhibited the expression of α-SMA, collagen-1, CXCL1/CXCL2, MLKL, and ICAM1 in HSC-LX2 cells.
MLKL inhibitor P28 suppressed TSZ-induced cytokine and chemokine production in monocytes.
MLKL inhibitor P28 reduced the expression of ICAM1 and CXCL1/2, which operate via a pathway different from the conventional necroptosis pathway.
Unlike the necrosulfonamide treatment, the P28 treatment did not induce cytotoxicity.
分子量 | 394.39 | |
分子式 | C20H18N4O5 | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Ju Hee Oh, et al. ACS Pharmacology & Translational Science, 2023.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright